Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AxoGen (DE:LT3)
BERLIN:LT3
AxoGen (LT3) Stock Price & Analysis
0 Followers
LT3 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€3.26 - €9.75
Previous Close€5.95
Volume0.00
Average Volume (3M)13.00
Market Cap
€263.24M
Enterprise Value€277.84M
Total Cash (Recent Filing)$31.02M
Total Debt (Recent Filing)$46.60M
Price to Earnings (P/E)N/A
Beta0.92
Next Earnings
May 02, 2024EPS Estimate
-€0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding43,206,246
10 Day Avg. Volume0
30 Day Avg. Volume13
Standard Deviation0.12
R-Squared0.00836
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)3.08
Price to Sales (P/S)3.42
Price to Cash Flow (P/CF)-332.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.75
Enterprise Value/Gross Profit2.17
Enterprise Value/Ebitda-22.34
Forecast
1Y Price Target
€14.53Price Target Upside144.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
AxoGen News
PremiumCompany Announcements
New Accounting & Financial Operations Risk for AxoGen – What’s the Latest?
PremiumCompany Announcements
AxoGen Releases Updated Corporate Presentation OnlinePremiumCompany Announcements
AxoGen Unveils Q4 and Full Year 2023 Financial Results
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.26% Other Institutional Investors
99.74% Public Companies and
Individual Investors
LT3 FAQ
What was AxoGen’s price range in the past 12 months?
AxoGen lowest stock price was €3.26 and its highest was €9.75 in the past 12 months.
What is AxoGen’s market cap?
Currently, no data Available
When is AxoGen’s upcoming earnings report date?
AxoGen’s upcoming earnings report date is May 02, 2024 which is today.
How were AxoGen’s earnings last quarter?
AxoGen released its earnings results on Mar 05, 2024. The company reported -€0.056 earnings per share for the quarter, beating the consensus estimate of -€0.067 by €0.01.
Is AxoGen overvalued?
According to Wall Street analysts AxoGen’s price is currently Undervalued.
Does AxoGen pay dividends?
AxoGen does not currently pay dividends.
What is AxoGen’s EPS estimate?
AxoGen’s EPS estimate is -€0.06.
How many shares outstanding does AxoGen have?
Currently, no data Available
What happened to AxoGen’s price movement after its last earnings report?
AxoGen reported an EPS of -€0.056 in its last earnings report, beating expectations of -€0.067. Following the earnings report the stock price went down -1.538%.
Which hedge fund is a major shareholder of AxoGen?
Among the largest hedge funds holding AxoGen’s share is Perceptive Advisors LLC. It holds AxoGen’s shares valued at 6M.
---
AxoGen Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€14.53 (144.22% Upside)
€14.53 (144.22% Upside)
Blogger Sentiment
Bullish
DE:LT3 Sentiment 100%
Sector Average 69%
Sector Average 69%
Insider Transactions
Sold Shares
Worth $544.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-35.64%
12-Months-Change
Fundamentals
Return on Equity
-22.08%
Trailing 12-Months
Asset Growth
0.74%
Trailing 12-Months
Company Description
AxoGen
AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
---
LT3 Earnings Call
Q4 2024
0:00 / 0:00
---
LT3 Stock 12 Months Forecast
Average Price Target
€14.53
▲(144.22% Upside)
Technical Analysis
Best Analysts Covering LT3
1 Year
1 Year Success Rate
6/20 ratings generated profit
1 Year Average Return
+4.25%
reiterated a buy rating 2 months ago
Copying David Turkaly's trades and holding each position for 1 Year would result in 30.00% of your transactions generating a profit, with an average return of +4.25% per trade.
---